Psychoactive substances have been used for centuries in various cultures to induce altered states of consciousness. In recent years there has been a resurgence in the study and use of psychedelics for therapeutic purposes. From synthetic substances like MDMA, LSD and ketamine, to plant medicines such as psilocybin, DMT, ayahuasca and mescaline, psychedelics are being tested in laboratories around the world to better understand their potential therapeutic benefits.
The renewed study of psychedelics has opened a new realm of possibilities for the treatment of PTSD, depression, anxiety, addictions and head injuries. By understanding how these substances interact with the brain and body, scientists can develop new treatments that could help millions of people suffering from mental health issues.
Laboratory testing helps ensure that plant medicines are safe for consumption by checking for pesticides, potency, solvents, metals and other contaminants. Testing also helps to verify the effectiveness and authenticity of the medicine by measuring its active ingredients and ensuring that it meets safety standards. Psychedelics testing and research ensures that people are getting access to high-quality plant medicines that will be effective in treating their conditions.
Conversations about psychedelics testing are especially timely right now with Oregon’s pioneering drug decriminalization legislation and the establishment of a Psilocybin Services program, both of which are expected to serve as models for legalization and regulation in other states. In anticipation of these emerging test areas, also timely is the launch of GenTech Scientific’s new Psilocybin Testing Package and our Psychedelic Start-Up Lab Options. Be sure to talk with our knowledgeable sales representatives about your lab’s specific needs!
Cureus Journal of Medical Science | Ziff et.al., 2022
A review of the use of psilocybin in the treatment of addictions, major depressive disorder, and end-of-life mood disorder.
Analysis of psilocybin and psilocin in Psilocybe subcubensis GUZMAN by ion mobility spectrometry and gas chromatography-mass spectrometry
Forensic Science International | 1998
A review of the use of ion mobility spectrometry in drug analysis, plus a simple and reliable quantitative GC/MS method.
Advancing Health & Wellbeing in the Military/Veteran Community: A Roundtable Discussion of Psychedelics & Mental Health
Bob Woodruff Foundation | 2022
Highlights of a roundtable discussion on psychedelics and mental health in the military and veteran community.
DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites
American Society for Microbiology | 2022
This study generates the first-ever insight into the highly complex and largely uncharacterized metabolomic profile for the most commonly cultivated magic mushroom, P. cubensis.
Pharmacological-assisted Psychotherapy for Post Traumatic Stress Disorder: a systematic review and meta-analysis
European Journal of Psychotraumatology | 2021
MDMA-assisted therapy was found to be statistically superior to active and inactive
placebo-assisted therapy in reduction of PTSD symptoms.
Oregon Environmental Laboratory Accreditation Program (ORELAP)| 2022
This protocol is for use by ORELAP-accredited laboratories performing psilocybin
product sampling as defined in OAR 333-064-0140. It focuses on standard and correct
sampling practices that should be reflected in a laboratory’s own sampling policies and
SCIEX USA | 2020
In this study, a 5-minute LC-MS/MS method has been developed for the quantification of psilocybin and psilocin in mushroom matrices.
Quantitative analysis of psilocybin and psilocin in Psilocybe baeocystis (Singer and Smith) by high-performance liquid chromatography and by thin-layer chromatography
Journal of Chromatography | 1981
Rapid quantification of psilocybin and psilocin in extracts of wild mushrooms is accomplished by reversed-phase high-performance liquid chromatography with paired-ion reagents.
The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry
Cureus | 2022
The goal of this study was to better characterize the recent uptrend in psychedelics in clinical trials and identify areas where potentially new clinical trials could be initiated.
Psychedelics Testing Systems by Application
GenTech has configured systems specifically to perform psychedelics testing. Click the button to request a quote and consult with a lab solutions specialist.
- Psilocybin Analysis
- Potency, Pesticides, Residual Solvents, Heavy Metals, Contaminants
- LSD Research/Analysis
- MDMA Research/Analysis
- DMT Research/Analysis
- Mescaline Research/Analysis